Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Naka

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1993
[Angiotensin II receptor antagonist activities and mode of action of benzimidazole-7-carboxylic acid derivatives]T Naka
Bio Systems|April 15, 1999
Evaluation of characteristic parameters for the neurotransmitter release mechanisms at the neuromuscular junctionT Naka
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 20, 2000
[Angiotensin II receptor antagonists]T Naka
Bio Systems|September 11, 1999
Localization effects of acetylcholine release from a synaptic vesicle at the neuromuscular junctionT Naka, N Sakamoto
Current Pharmaceutical Design|July 3, 1999
A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetilT Naka, K Kubo
Iryo|March 1, 1970
[Experience in postoperative long-term M.M.C. therapy of malignant ovarian tumor in a child]S Fukuoka, T Naka
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 6, 2000
[Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist]Y Inada, T Naka
Bio Systems|January 1, 1986
Validity of transfer-function representation of input-output relation in allosteric modelsN Sakamoto, T Naka
Trends in Biochemical Sciences|September 29, 1999
Negative regulation of cytokine signaling: STAT-induced STAT inhibitorT Naka, M Fujimoto, T Kishimoto
Methods in Molecular Medicine|February 23, 2011
Measurement of Protein Expression of p53, p21(WAF1), and Rb in Patients with Surgically Treated Hepatocellular Carcinoma by Using Catalyzed Signal-Amplification SystemT Naka, T Kaneko, N Kaibara
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1993
[Angiotensin II receptor antagonist activities and mode of action of benzimidazole-7-carboxylic acid derivatives]T Naka
Bio Systems|April 15, 1999
Evaluation of characteristic parameters for the neurotransmitter release mechanisms at the neuromuscular junctionT Naka
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 20, 2000
[Angiotensin II receptor antagonists]T Naka
Bio Systems|September 11, 1999
Localization effects of acetylcholine release from a synaptic vesicle at the neuromuscular junctionT Naka, N Sakamoto
Current Pharmaceutical Design|July 3, 1999
A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetilT Naka, K Kubo
Iryo|March 1, 1970
[Experience in postoperative long-term M.M.C. therapy of malignant ovarian tumor in a child]S Fukuoka, T Naka
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 6, 2000
[Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist]Y Inada, T Naka
Bio Systems|January 1, 1986
Validity of transfer-function representation of input-output relation in allosteric modelsN Sakamoto, T Naka
Trends in Biochemical Sciences|September 29, 1999
Negative regulation of cytokine signaling: STAT-induced STAT inhibitorT Naka, M Fujimoto, T Kishimoto
Methods in Molecular Medicine|February 23, 2011
Measurement of Protein Expression of p53, p21(WAF1), and Rb in Patients with Surgically Treated Hepatocellular Carcinoma by Using Catalyzed Signal-Amplification SystemT Naka, T Kaneko, N Kaibara
Pageof 14